Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products

Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction

doi:10.1161/STROKEAHA.117.019216

Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products

Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction

Hokkaido University

Research output: Contribution to journal › Review article › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	e145-e152
Journal	Stroke
Volume	49
Issue number	4
DOIs	https://doi.org/10.1161/STROKEAHA.117.019216
Publication status	Published - 2018 Apr 1

Keywords

cell- and tissue-based therapy
cerebral infarction
clinical trial
regenerative medicine
stroke

Access to Document

10.1161/STROKEAHA.117.019216

Cite this

@article{67128d06846f4b5eabb3cc6063bf7976,

title = "Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products",

keywords = "cell- and tissue-based therapy, cerebral infarction, clinical trial, regenerative medicine, stroke",

author = "{Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction} and Kiyohiro Houkin and Hideo Shichinohe and Koji Abe and Teruyo Arato and Mari Dezawa and Osamu Honmou and Nobutaka Horie and Yasuo Katayama and Kohsuke Kudo and Satoshi Kuroda and Tomohiro Matsuyama and Ichiro Miyai and Izumi Nagata and Kuniyasu Niizuma and Ken Sakushima and Masanori Sasaki and Norihiro Sato and Kenji Sawanobori and Satoshi Suda and Akihiko Taguchi and Teiji Tominaga and Haruko Yamamoto and Toru Yamashita and Toshiki Yoshimine",

year = "2018",

month = apr,

day = "1",

doi = "10.1161/STROKEAHA.117.019216",

language = "English",

volume = "49",

pages = "e145--e152",

journal = "Stroke",

issn = "0039-2499",

publisher = "American Heart Association",

number = "4",

}

TY - JOUR

T1 - Accelerating Cell Therapy for Stroke in Japan

T2 - Regulatory Framework and Guidelines on Development of Cell-Based Products

AU - Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction

AU - Houkin, Kiyohiro

AU - Shichinohe, Hideo

AU - Abe, Koji

AU - Arato, Teruyo

AU - Dezawa, Mari

AU - Honmou, Osamu

AU - Horie, Nobutaka

AU - Katayama, Yasuo

AU - Kudo, Kohsuke

AU - Kuroda, Satoshi

AU - Matsuyama, Tomohiro

AU - Miyai, Ichiro

AU - Nagata, Izumi

AU - Niizuma, Kuniyasu

AU - Sakushima, Ken

AU - Sasaki, Masanori

AU - Sato, Norihiro

AU - Sawanobori, Kenji

AU - Suda, Satoshi

AU - Taguchi, Akihiko

AU - Tominaga, Teiji

AU - Yamamoto, Haruko

AU - Yamashita, Toru

AU - Yoshimine, Toshiki

PY - 2018/4/1

Y1 - 2018/4/1

KW - cell- and tissue-based therapy

KW - cerebral infarction

KW - clinical trial

KW - regenerative medicine

KW - stroke

UR - http://www.scopus.com/inward/record.url?scp=85052005856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052005856&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.117.019216

DO - 10.1161/STROKEAHA.117.019216

M3 - Review article

C2 - 29581346

AN - SCOPUS:85052005856

SN - 0039-2499

VL - 49

SP - e145-e152

JO - Stroke

JF - Stroke

IS - 4

ER -

Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products

Keywords

Access to Document

Other files and links

Cite this